Guardian Pharmacy Services, Inc. Class A ( (GRDN) ) just unveiled an announcement.
Guardian Pharmacy Services, Inc. announced preliminary unaudited financial results for Q4 and full year 2024, showing a strong performance with a 20.5% increase in Q4 revenue driven by organic growth, acquisitions, and increased vaccinations. Despite a decrease in net income due to tax provisions and share-based compensation expenses, the company reported a 30.3% increase in adjusted EBITDA. Guardian provided 2025 guidance with expected revenue between $1.330 billion and $1.350 billion, and adjusted EBITDA between $97.0 million and $101.0 million, indicating a positive outlook for the coming year.
More about Guardian Pharmacy Services, Inc. Class A
Guardian Pharmacy Services is a leading long-term care pharmacy services company that provides technology-enabled services to help residents of long-term health care facilities adhere to their drug regimen, aiming to reduce care costs and improve clinical outcomes. As of December 31, 2024, the company operated 51 pharmacies serving approximately 186,000 residents in about 7,000 LTCFs across 38 states.
YTD Price Performance: 0.55%
Average Trading Volume: 137,943
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $1.27B
Find detailed analytics on GRDN stock on TipRanks’ Stock Analysis page.